Metropolitan Digital

Men's Weekly


.

A lab-stage mRNA vaccine targeting ticks may offer protection against Lyme and other tick-borne diseases

  • Written by Andaleeb Sajid, Staff Scientist, National Institutes of Health
A lab-stage mRNA vaccine targeting ticks may offer protection against Lyme and other tick-borne diseasesAs the rate of tick-borne diseases rises, vaccines that stop ticks in their tracks could be an essential preventive tool.rbkomar/Moment via Getty Images

The Research Brief is a short take about interesting academic work.

The big idea

A new laboratory-stage mRNA vaccine that teaches the immune system to recognize the saliva from tick bites could...

Read more: A lab-stage mRNA vaccine targeting ticks may offer protection against Lyme and other tick-borne...

Metropolitan republishes selected articles from The Conversation USA with permission

Visit The Conversation to see more